Liza Porteus Viana

Liza Porteus Viana

Patent Reform, Piracy, Generic Drug Issues Likely For US Congress This Year

Although attempts to repeal last year’s healthcare reform bill and efforts to get the deficit under control may take up much of the United States Congress’ time this year, lawmakers are expected to tackle a number of intellectual property-related priorities lawmakers, including patent reform, internet neutrality, and enforcement during the new 112th session.

The 2011 Drug Patent ‘Cliff’ And The Evolution Of IP Valuation

In today’s global economy, there is an increasing convergence of intellectual property and finance. Wall Street is grappling with how to recognise the true value of a firm’s intellectual property. Companies are realising that simply accumulating patents does not necessarily increase their firms’ value, but it is how those patents are used that can attract capital. And drug companies facing massive numbers of upcoming patent expiries, a deflated economy and other market pressures, are looking to diversify their portfolios to stay in the black.

US FDA’s Tough Road Ahead In Creating Pathway For Life-Saving Biologics

The US Food and Drug Administration heard from myriad pharmaceutical companies, patient groups, and other stakeholders last week as the agency considers how to create an abbreviated pathway to bring more biologic drugs to market.

New US IP Enforcement Plan May Have International Impact

The Obama administration’s release of its national intellectual property strategy yesterday was welcomed by many groups representing businesses and intellectual property holders who said it could serve as an example to other countries.

US Advisory Group Looks At FCC Net Neutrality Principles As Decision Looms

A technical advisory group is working to drill down on key issues surrounding the US Federal Communications Commission’s proposed internet neutrality principles, but the agency is prepared to make a final decision in the end about how those principles are implemented, a senior FCC official said Thursday.

US, WIPO Officials Assess Patent Reform, PCT, Copyright Priorities

NEW YORK - Republican and Democratic lawmakers in the United States are “hotlining” colleagues to ascertain if there is any objection to moving patent reform quickly through the US Senate, a representative of a major stakeholder in the debate said here Friday. Meanwhile, the US Copyright Office is working to get its priorities through a restructured Congress, and a World Intellectual Property Organization official warned of a possible divide in WIPO's norm-setting activities.

Global Anti-Counterfeiting Efforts Set To Rise Further

NEW YORK – The problem of global counterfeiting has not diminished with the new year, experts said here yesterday, and 2010 promises to bring even more rampant intellectual property theft if countries do not do more to stem the problem. Some countries are mobilising to do just that.

2010 US Industry Group Priorities: Patent Reform, USPTO Funds, Genes, Green Tech

Along with a domestic agenda that includes patent reform and improving the efficiency of the US Patent and Trademark Office, the American Intellectual Property Law Association (AIPLA) this year also is eyeing issues at the international level, such as genetic resources, environmental technologies and international patent harmonisation.

Year Ahead: Range Of IP Policy Issues May See Action In United States In 2010

With the United States Congress attempting to wrap up healthcare – a move made more difficult after a Republican won a traditionally Democratic US Senate seat in January - issues such as tax increases for the nation’s largest financial institutions, energy reform and others may take centre stage. But that’s not to say there is not some room for intellectual property issues to be considered. Upcoming issues may include patent reform, biologic drugs, internet neutrality, enforcement, and performance rights.